PropertyValue
?:abstract
  • Vitamin D (VitD) deficiency is considered a global problem and might be associated with increased susceptibility to COVID‐19 illness. In the light of COVID‐19 pandemic, VitD might be a promising agent for fighting the SARS‐CoV‐2, since VitD is involved in various pathophysiological mechanisms that occur during COVID‐19 infection. High‐dose VitD supplementation, particularly for risk groups, could be recommended to achieve and maintain optimal (range 40‐60 ng/mL) serum 25‐hydroxy vitamin D levels (marker of VitD status) both for COVID‐19 prevention and treatment.
?:creator
?:doi
  • 10.1111/ijcp.13748
?:doi
?:journal
  • Int_J_Clin_Pract
?:license
  • no-cc
?:pdf_json_files
  • document_parses/pdf_json/cd1956aa9b4515712c40d07a5152c0a525aa8d4d.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7646035.xml.json
?:pmcid
?:pmid
?:pmid
  • 33012103.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Medline; PMC
?:title
  • Vitamin D and COVID‐19: It is time to act
?:type
?:year
  • 2020-10-27

Metadata

Anon_0  
expand all